ARTES Biotechnology - globally active R&D company, specialized in developing biopharmaceutical production processes. Since 2002, ARTES has positioned itself as a valued partner for the pharmaceutical industry with proprietary expression systems and its competence from cell line development to manufacturing. We have positioned ourselves as a valued partner for the pharmaceutical industry with several technology transfers successfully implemented worldwide at clients' sites. Today, ARTES is a strong, well-established partner for the development of customer driven projects up to supply of pre-clinical material. In addition, we are developing own virus like particle (VLP) based vaccine candidates up to proof-of-concept in animals.